Clinical Aspects of Hypertension Anna Maio, M.D..
-
Upload
alexandra-dean -
Category
Documents
-
view
218 -
download
2
Transcript of Clinical Aspects of Hypertension Anna Maio, M.D..
![Page 1: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/1.jpg)
Clinical Aspects of Hypertension
Anna Maio, M.D.
![Page 2: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/2.jpg)
Incidence and Prevalence58-65 million Americans
30% incidence in the 18 and older age group
1/2 of people over 65 are hypertensive 15% of whites and 25% of African
Americans--reason unknown More common in men than in women up to
the age of 50.
![Page 3: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/3.jpg)
JNC 7 Report-JAMA-May, 2003 Classification of BP
Systolic Diastolic
Normal <120 and <80
Prehyper-
tension
120-139 or 80-99
Stage 1 140-159 or 90-99
Stage 2 >160 or >100
![Page 4: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/4.jpg)
Definition of Isolated Systolic Hypertension
Systolic blood pressure>160 mmHg Diastolic blood pressure< or = 90 mmHg Prevalence increases with age 11.7% of individuals >80 years of age 50% higher prevalence in women and
African Americans
![Page 5: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/5.jpg)
Emergent/Urgent Hypertension
DBP>120 mmHg and papilledema (malignant)
Usually renal failure or stroke or chest pain or confusion or hemolytic anemia is present
Requires admission to an ICU, arterial line and parenteral treatment
![Page 6: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/6.jpg)
Risk Factors for Essential HTN
More common and more severe in blacks Relationship between sodium intake and
hypertension Association between excess alcohol and
HTN Increased prevalence of obesity More common among those with hostile
attitudes
![Page 7: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/7.jpg)
Identifiable Causes of Hypertension
Chronic kidney disease and renovascular disease (5-10%)
Sleep apnea Chronic steroid therapy/Cushing syndrome Primary aldosteronism Pheochromocytoma Coarctation of the aorta Thyroid or parathyroid disease
![Page 8: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/8.jpg)
Identifiable CausesDrug-Induced or Drug-Related
NSAIDS/COX-2 inhibitors Cocaine, amphetamines, other illicit drugs Sympathomimetics OCPs Adrenal steroids Cyclosporine and tacrolimus Erythropoietin Licorice
![Page 9: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/9.jpg)
History
Duration of disease Prior treatment including drugs, doses, side
effects Use of estrogens, steroids, sympathomimetics,
etc. (drugs taken are essential) Family history of HTN, early cardiac death,
pheo, renal disease ROS focuses on the target organs
![Page 10: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/10.jpg)
Physical Exam
Measurement of BP in both arms, BMI Fundi Auscultation for carotid, abdominal, and
femoral bruits Palpation of the thyroid Heart, lungs, abdomen Edema and pulses Neuro assessment
![Page 11: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/11.jpg)
Laboratory and Other Studies
Urinalysis Glucose, serum potassium, creatinine, calcium Hematocrit? TSH? Pregnancy test? EKG? Lipids?
![Page 12: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/12.jpg)
Essential vs.. Secondary Causes
Use clues in the history and physical to order other testing
Acute BP rise over stable baseline Age<20 or >50 years of age Severe HTN with retinal involvement Unexplained hypokalemia No family history Abdominal bruit
![Page 13: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/13.jpg)
Complication Associated With Untreated Hypertension
Coronary Artery Disease Cerebrovascular Disease Left ventricular hypertrophy with
congestive heart failure Renal failure Aortic dissection Retinal hemorrhages/papilledema
![Page 14: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/14.jpg)
Cardiovascular Disease Risk
Relationship is independent of other risk factors
The higher the BP the greater the chance of MI, HF, stroke, and kidney disease
Stage 1 and risk factors--12 mmHg decrease in systolic BP for 10 years will prevent 1 death for every 11 treated patients
![Page 15: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/15.jpg)
Benefits of Treatment
35-40% mean reduction in stroke 20-25% in myocardial infarction 50% reduction in heart failure
![Page 16: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/16.jpg)
Initial Drug Therapy
Without CI With CI
Prehyper-tension
No drugtreatment
Drug Tx forCI
Stage 1 Thiazidediuretics formost
Drug Tx forCI//Others asneeded
Stage 2 2 DrugCombinationsfor most
Drug Tx forCI//Others asneeded
![Page 17: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/17.jpg)
Treatment
Lifestyle changes Treatment of
hypertension with and without CI
Initiating therapy with 2 drugs if > 20/10 mmHg over goal/side effect problems
Use thiazide diuretics
![Page 18: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/18.jpg)
Lifestyle Modifications
Weight reduction BMI=18.5-24.9 Adopt DASH eating plan Consume diet rich
in fruits, veggies, and low-fat dairy Dietary sodium reduction Physical activity Regular aerobic activity at
least 30 minutes/day most days/week Moderation of alcohol consumption No more
than 2/day
![Page 19: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/19.jpg)
Compelling Indications
HF-diuretic, beta-blocker, ACEI, ARB, aldosterone antagonist
Post-MI-beta-blocker, ACEI, aldosterone antagonist
High coronary disease risk-diuretic, beta-blocker, ACEI, CCB
Diabetes-diuretic, beta-blocker, ACEI, ARB, CCB
![Page 20: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/20.jpg)
Compelling Indications
Chronic kidney disease-ACEI, ARB Recurrent stroke prevention-diuretic, ACEI
![Page 21: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/21.jpg)
Favorable Drug Effects
Thiazides are useful in slowing the demineralization in osteoporosis
Beta-blockers can be used to treat arrhythmias, migraine, thyrotoxicosis, tremor, or stage fright
CCBs can be used in Raynaud’s and some arrhythmias
Alpha-blockers may be useful in prostatic hypertrophy
![Page 22: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/22.jpg)
Unfavorable Drug Effects
Pregnancy--methyldopa, beta-blockers, and vasodilators; ACEI and ARBs are contraindicated because of fetal defects and should be avoided in women who are likely to get pregnant
Thiazides should be used with caution in gout or a history of hyponatremia
Avoid beta-blockers in reactive airway disease or heart block
![Page 23: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/23.jpg)
Creating a Drug Regimen
Choose first drug very carefully; often a thiazide Bring patient back in 1-2 weeks Add second drug if needed; if first drug is not a
diuretic the second one should be Third drug is often a CCB or an alpha2 agonist If the patient requires a 4th drug it is usually a
potent vasodilator
![Page 24: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/24.jpg)
Drug Regimen for Isolated Systolic Hypertension
Drugs shown to be of benefit (>33% reduction in stroke) are thiazide diuretics and beta-blockers
Always check orthostatic blood pressure since this can effect quality of life
![Page 25: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/25.jpg)
Drug Regimens for Accelerated Hypertension
All drugs should be given in a monitered setting-CCU or ICU; consider an arterial line
Drugs should be given parenterally Volume overload is common; assess need for
loop diuretic Nitroprusside, Enalapril, Esmolol, Cardizem
are just a few of the drugs available IV now
![Page 26: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/26.jpg)
Physicians’ Role
Strive for optimal blood pressure control Look for identifiable causes and
treat/eliminate when possible Partner with the patient to choose the best
drug regimen considering cost, convenience, side effects
Follow-up and education
![Page 27: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/27.jpg)
Improving Hypertension Control
Clinical inertia
![Page 28: Clinical Aspects of Hypertension Anna Maio, M.D..](https://reader030.fdocuments.us/reader030/viewer/2022032607/56649ed45503460f94be4e8b/html5/thumbnails/28.jpg)
Questions?????